Monoclonal Antibodies Quality & Regulatory Requirements

The Monoclonal Antibodies Quality & Regulatory Requirements conference delivers advanced insights into biologics quality standards, regulatory compliance, and monoclonal antibody development strategies for the pharmaceutical and biotechnology industries. The program covers key topics including International Council for Harmonisation guidance updates, Quality by Design (QbD), process validation, analytical characterization, comparability protocols, lifecycle management, and manufacturing control strategies. Participants will explore regulatory expectations for biosimilars, antibody-drug conjugates, and advanced biologics through expert-led sessions, case studies, and interactive discussions. Designed for professionals in regulatory affairs, quality assurance, manufacturing, R&D, and CMC, the conference provides practical industry-focused compliance solutions.